医薬品ろ過市場：現状分析・予測 (2022年～2028年)

世界の医薬品ろ過の市場規模は予測期間中に約14％という著しい成長を示すと予想されています。

医薬品ろ過は、浮遊粒子の分離のための必須要件と定義され、ろ過は製薬業界の一般的な慣行として成長してきました。洗浄に関する厳しい規制や多数の高分子化合物の製造の増加により、製薬会社はろ過技術に投資を行っています。さらに、予防接種の生産がかつてないほどの勢いで増加していることも、ろ過の採用を促しています。さらに、ろ過の世界的なニーズは、糖尿病、癌、関節炎などの慢性疾患の治療のための最先端の医薬品に対する需要の高騰によってももたらされる見通しです。

当レポートでは、世界の医薬品ろ過の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、需給動向、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 市場イントロダクション

第2章 調査手法・前提因子

第3章 市場概要

第4章 エグゼクティブサマリー

第5章 COVID-19：医薬品ろ過市場への影響

第6章 医薬品ろ過市場：収益の推移・予測

第7章 市場洞察：製品別

• メンブレンフィルター
• プレフィルター・深部メディアフィルター
• カートリッジ＆カプセルフィルター
• 使い捨てシステム
• フィルターホルダー
• ろ過用付属品
• その他

第8章 市場洞察：手法別

• 精密ろ過
• 限外ろ過
• ナノろ過
• その他

第9章 市場洞察：用途別

• 最終製品処理
• 原料ろ過
• 細胞分離
• 浄水
• 空気浄化

第10章 市場洞察：事業規模別

• 製造規模
• パイロット規模
• R&D規模

第11章 市場洞察：地域別

• 北米
• 欧州
• アジア太平洋
• その他の地域

第12章 医薬品ろ過市場：市場力学

• 市場促進要因
• 市場の課題
• 影響分析

第13章 医薬品ろ過市場：市場機会

第14章 医薬品ろ過市場：市場動向

第15章 需要サイド・供給サイドの分析

• 需要サイド分析
• 供給サイド分析

第16章 バリューチェーン分析

第17章 価格分析

第18章 戦略的洞察

第19章 競合シナリオ

第20章 企業概要

• Merck KGaA
• General Electric Company
• Pall Corporation
• PARKER HANNIFIN CORP
• Sartorius AG
• 3M
• Eaton Corporation PLC
• Amazon Filters Ltd.
• Graver Technologies
• Meissner Filtration Products Inc

第21章 免責事項

Global Pharmaceutical Filtration Market is expected to grow at a significant rate of around 14% during the forecast period. Pharmaceutical filtration is defined as an order to help separate suspended particles, filtration has grown to be a common practice in the pharmaceutical industry. Due to strict cleaning regulations and an increase in the manufacture of numerous big molecules, pharmaceutical companies are investing in filtration technology. Additionally, the production of vaccinations has increased at a never-before-seen rate, which has prompted the employment of filtration methods. The global need for filtration will be driven by soaring demand for cutting-edge medicinal medications for the treatment of chronic ailments like diabetes, cancer, and arthritis. Thus, the growing focus and investment of key stakeholders in the research and development of technologically advanced pharmaceutical filtration is further expected to support market growth. For instance, In May 2021, Meissner secured around US$ 13.4 million contract from BARDA, the U.S. government agency, to bolster the production capability for components needed for vaccines and therapies. The company would be manufacturing single-use systems for filtration, filling assemblies, bottle assemblies and bio-container assemblies, etc.

Merck KGaA, General Electric Company, Pall Corporation, Parker Hannifin Corporation, Sartorius Stedim Biotech S.A., 3M, Eaton Corporation PLC, Amazon Filters Ltd., Graver Technologies, LLC, Meissner Filtration Products, Inc. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst product, single-use systems held a significant CAGR during the forecast period"

Based on product, the market is segmented into membrane filters, prefilters & depth media filters, cartridge & capsule filters, single-use systems, filter holders, filtration accessories, and others. The single-use systems category held a significant CAGR during the forecast period. The single-use systems provide a number of benefits, such as a lower risk of contamination, shorter operating times, and convenience. As a result, it is anticipated that the need for single-use systems would increase soon. Additionally, they are small in size and take up less space in manufacturing environments.

"Amongst technique, the ultrafiltration to hold a significant share in the market in 2020"

Based on the technique, the market is categorized into microfiltration, ultrafiltration, nanofiltration, and others. Among these, ultrafiltration held a significant share in 2020. The best applications for ultrafiltration, a pressure-driven membrane transport method, are the separation, concentration, and purification of certain macromolecules. In the industrial setting, this filtration technique is used to produce goods with a high level of purity, including vaccines, plasma, and serums.

"North America to hold a significant share in the market"

In 2020, North America held a significant share of the global pharmaceutical filtration market. The major factor such as increased demand for pharmaceutical filtration consumption and higher developments in the pharmaceutical and biotechnology industries in the region. Furthermore, improvements in healthcare infrastructure, the rising number of drug development projects, significant spending on R&D activities, increased healthcare reforms, and technical breakthroughs in the field of healthcare all contribute to market growth. As per the Congressional Budget Office, in 2021, Spending on R&D in the pharmaceutical industry and the introduction of new drugs have both increased in the past two decades.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

The global pharmaceutical filtration market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Pharmaceutical Filtration Market
• 2.2. Research Methodology of the Pharmaceutical Filtration Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE PHARMACEUTICAL FILTRATION MARKET

6 PHARMACEUTICAL FILTRATION MARKET REVENUE (USD BN), 2020-2028F

7 MARKET INSIGHTS BY PRODUCT

• 7.1. Membrane Filters
• 7.2. Prefilters & Depth Media Filters
• 7.3. Cartridge & Capsule Filters
• 7.4. Single-Use Systems
• 7.5. Filter Holders
• 7.6. Filtration Accessories
• 7.7. Others

8 MARKET INSIGHTS BY TECHNIQUE

• 8.1. Microfiltration
• 8.2. Ultrafiltration
• 8.3. Nanofiltration
• 8.4. Others

9 MARKET INSIGHTS BY APPLICATION

• 9.1. Final Product Processing
• 9.2. Raw Material Filtration
• 9.3. Cell Separation
• 9.4. Water Purification
• 9.5. Air Purification

10 MARKET INSIGHTS BY SCALE OF OPERATION

• 10.1. Manufacturing-Scale
• 10.2. Pilot-Scale
• 10.3. R&D-Scale

11 MARKET INSIGHTS BY REGION

• 11.1. North America
  • 11.1.1. The U.S.
  • 11.1.2. Canada
  • 11.1.3. Rest of North America
• 11.2. Europe
  • 11.2.1. Germany
  • 11.2.2. The U.K.
  • 11.2.3. France
  • 11.2.4. Italy
  • 11.2.5. Spain
  • 11.2.6. Rest of Europe
• 11.3. Asia-Pacific
  • 11.3.1. China
  • 11.3.2. Japan
  • 11.3.3. India
  • 11.3.4. Rest of Asia-Pacific
• 11.4. Rest of World

12 PHARMACEUTICAL FILTRATION MARKET DYNAMICS

• 12.1. Market Drivers
• 12.2. Market Challenges
• 12.3. Impact Analysis

13 PHARMACEUTICAL FILTRATION MARKET OPPORTUNITIES

14 PHARMACEUTICAL FILTRATION MARKET TRENDS

15 DEMAND AND SUPPLY-SIDE ANALYSIS

• 15.1. Demand Side Analysis
• 15.2. Supply Side Analysis

16 VALUE CHAIN ANALYSIS

17 PRICING ANALYSIS

18 STRATEGIC INSIGHTS

19 COMPETITIVE SCENARIO

• 19.1. Competitive Landscape
  • 19.1.1. Porters Five Forces Analysis

20 COMPANY PROFILED

• 20.1. Merck KGaA
• 20.2. General Electric Company
• 20.3. Pall Corporation
• 20.4. PARKER HANNIFIN CORP
• 20.5. Sartorius AG
• 20.6. 3M
• 20.7. Eaton Corporation PLC
• 20.8. Amazon Filters Ltd.
• 20.9. Graver Technologies
• 20.10. Meissner Filtration Products Inc

21 DISCLAIMER